The Role of PET-CT in Mediastinal Lymph Node Staging in Non-small Cell Lung Cancer

被引:0
|
作者
Bellek, Ebru [1 ]
Erturan, Salih Serdar [1 ]
Hallac, Metin [3 ]
Sonmezoglu, Kerim [3 ]
Kaynak, Kamil [2 ]
Bozkurt, Kursat [2 ]
Akman, Canan [4 ]
Oz, Buge [5 ]
Yaman, Mustafa [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Tip Fak, Gogus Hastaliklari AD, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Tip Fak, Gogus Cerrahisi AD, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Tip Fak, Nukleer Tip AD, Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Tip Fak, Radyol AD, Istanbul, Turkey
[5] Istanbul Univ, Cerrahpasa Tip Fak, Patol AD, Istanbul, Turkey
关键词
positron emission tomography (PET); standart uptake value (SUV);
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Aim: The aim of this study was to determine the overall accuracy, sensitivity and specificity of both CT and PET-CT in identifying and classifying the presence of metastatic intra-thoracic lymph nodes and their potential role in the treatment of lung cancer. Material and methods: Forty four (mean age 60.7, male/female ratio: 37/7) patients with potentially resectable non-small cell lung cancer have been enrolled. All patients underwent flexibl bronchoscopy, CT scanning and PET-CT imaging prior to mediastinoscopy. Mediastinostomy was performed in two patients. Thirty three patients with negative mediastinoscopy and three patients after neoadjuvant chemotherapy, total of 37 patients went through thoracotomy. Results: The overall sensitivity, specificity and accuracy of CT scan in preoperative staging were found 66.7%, 62.1%, 63.6%, respectively. The negative and positive predictive values of CT scan were 78.3% and 47.6%. CT imaging correctly identified 29 patients (65.9%). Seven patients (15.9%) were under-staged while eight patients (18.1%) were over-staged. Based on PETCT findings, overall sensitivity, specificity and accuracy for staging mediastinal lymph nodes were 86.7%, 65.5% and 72.7%, respectively. The negative and positive predictive values of PET-CT were as follows; 90.5% and 56.5%. Overall, interpretations based on PET-CT staged 65.9% (29 patients) correctly, down-staged six patients (13.6%) and over-staged nine patients. The false-negative rate was 13.3% while the false-positive rate was 34.5%. Conclusion: CT scan and PET-CT perform similarly in the mediastinal staging of non-small cell lung cancer (p= 0.05, Mc Nemar test), both tests are conditionally dependent and provide complementary information, and their diagnostic value mainly resides on the negative results. Although, statistically insignificant, PET-CT has a superior sensitivity and better negative predictive value over CT scan. Based on the relationship between SUV-max value and characteristics of tumor, a significant increase in SUV-max value appeared to be correlated with the tumor size and squamous cell carcinoma sub-type.
引用
下载
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [21] TIME-OF-FLIGHT PET/CT IN MEDIASTINAL STAGING OF NON-SMALL CELL LUNG CANCER
    Huang, Y-T T.
    Wu, P.
    Chong, S.
    Shon, I. Ho
    Lin, P.
    Lin, M.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 7 - 8
  • [22] Endosonographic Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer: How I Teach It
    Oliveira, Ricardo L.
    Liberman, Moishe
    ANNALS OF THORACIC SURGERY, 2017, 104 (01): : 18 - 21
  • [23] Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?
    Lee, Sang Woo
    Kim, Seong-Jang
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) : 414 - 421
  • [24] Mediastinal lymph node staging of non-small cell lung cancer with F-18 FDG PET/CT in a tuberculosis-endemic country
    Lee, H.
    Yang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S509 - S510
  • [25] Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
    Fischer, Barbara M.
    Mortensen, Jann
    Hansen, Hanne
    Vilmann, Peter
    Larsen, Soren S.
    Loft, Annika
    Bertelsen, Anne K.
    Ravn, Jesper
    Clementsen, Paul
    Hoegholm, Asbjorn
    Larsen, Klaus R.
    Dirksen, Asger
    Skov, Birgit G.
    Krasnik, Mark
    Hojgaard, Liselotte
    Lassen, Ulrik
    THORAX, 2011, 66 (04) : 294 - 300
  • [26] Re: 'PET-CT in non-small cell lung cancer staging-promises and problems'
    Barnes, D.
    Entwistle, J.
    CLINICAL RADIOLOGY, 2008, 63 (01) : 108 - 110
  • [27] The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer
    Melek, Huseyin
    Gunluoglu, Mehmet Zeki
    Demir, Adalet
    Akin, Hasan
    Medetoglu, Baris
    Kara, Hasan Volkan
    Olcmen, Aysun
    Dincer, Seyyit Ibrahim
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (01): : 56 - 63
  • [28] What is the shelf life of PET-CT staging of the mediastinum in non-small cell lung cancer?
    Hanna, G. G.
    McManus, K. G.
    Lynch, T.
    Gracey, G.
    O'Sullivan, J. M.
    McAleese, J.
    LUNG CANCER, 2009, 63 : S24 - S24
  • [29] Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer
    Wang, G.
    Zhang, C.
    Liu, H.
    Yu, Z.
    Liu, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1056 - S1056
  • [30] PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
    Kernstine, KH
    Stanford, W
    Mullan, BF
    Rossi, NP
    Thompson, BH
    Bushnell, DL
    McLaughlin, KA
    Kern, JA
    ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1022 - 1028